Leflunomide 20 mg

DRUG3 trials

Sponsors

Elisabeth Brouwer, University Hospital, Basel, Switzerland, Tata Memorial Centre

Conditions

Hematologic MalignanciesMEN1 Gene MutationPolymyalgia Rheumatica

Phase 2

Leflunomide to Prevent Cytomegalovirus Reactivation in Stem Cell Transplant Patients

RecruitingNCT07709013

Tata Memorial CentreHematologic Malignancies

Start: 2024-10-18End: 2029-04-01Target: 22Updated: 2026-07-16

Phase 3

Treatment With Leflunomide in Patients With Polymyalgia Rheumatica

Elisabeth BrouwerPolymyalgia Rheumatica

Start: 2019-03-01End: 2022-11-01Target: 94Updated: 2019-06-03

Unknown Phase

Leflunomide Treatment for MEN1 Patients - the LUMEN1 Trial

TerminatedNCT05605587

University Hospital, Basel, SwitzerlandMEN1 Gene Mutation

Start: 2023-05-02End: 2026-01-13Updated: 2026-01-27